In vivo gene transfer to dopamine neurons of rat substantia nigra via the high-affinity neurotensin receptor

Molecular Medicine

Volumn 7, Issue 3, 2001, Pages 186-192

  Alvarez Maya, Ikuri ^a   Navarro Quiroga, Ivan ^b   Meraz Ríos, Marco Antonio ^a   Aceves, Jorge ^b   Martinez Fong, Daniel ^b,c  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b Ciudad Universitaria   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; DOPAMINE; GREEN FLUORESCENT PROTEIN; NEUROTENSIN RECEPTOR; PHOTOPROTEIN; PYRAZOLE DERIVATIVE; QUINOLINE DERIVATIVE;

ANIMAL; ARTICLE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; GLIA; MALE; METABOLISM; NERVE CELL; RAT; REPORTER GENE; SUBSTANTIA NIGRA; WISTAR RAT;

ANIMALS; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA; DOPAMINE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MALE; NEUROGLIA; NEURONS; PYRAZOLES; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, NEUROTENSIN; SUBSTANTIA NIGRA;

EID: 0035291044     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401952     Document Type: Article

References (39)

1. Garcia-Valenzuela E, Rayanade R, Perales JC, Davidson CA, Hanson RW, Sharma SC. (1997) Axon-mediated gene transfer of retinal ganglion cells in vivo. J. Neurobiol. 32: 111-122.
2. Naldini L, Blömer U, Gallay P, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
3. Wu CH, Wilson JM, Wu GY. (1989) Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J. Biol. Chem. 264: 16985-16987.
4. Martinez-Fong D, Mullersman JE, Purchio AF, Armendariz-Borunda J, Martinez-Hernandez A. (1994) Nonenzymatic glycosylation of poly-L-lysine: a new tool for targeted gene delivery. Hepatology 20: 1602-1608.
5. Feigner PL, Barenholz Y, Behr JP, et al. (1997) Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. 8: 511-512.
6. Ziady AG, Ferkol T, Dawson DV, Perlmutter DH, Davis PB. (1999) Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J. Biol. Chem. 274: 4908-4916.
7. Bunnell BA, Askari FK, Wilson, JM. (1992) Targeted delivery of antisense oligonucleotides by molecular conjugates. Somat. Cell Mol. Gen. 18: 559-569.
8. Kollen WJW, Mulberg AE, Wei XF, et al. (1999) High-efficiency transfer of cystic-fibrosis transmembrane conductance regulator cDNA Into cystic-fibrosis airway cells in culture using lactosylated polylysine as a vector. Hum. Gene Ther. 10: 615-622.
9. Wu GY, Wilson JM, Shalaby F, Grossman M, Shafritz DA, Wu CH. (1991) Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. J. Biol. Chem. 266: 14338-14342.
10. Faure MN, Alonso A, Nouel D, Gaudriault G, Dennis M, Vincent JP, Beaudet A. (1995) Somatodendritic internalization and perinuclear targeting of neurotensin in the mammalian brain. J. Neurosci. 15: 4140-4147.
11. Nouel D, Faure MP, St Pierre JA, Alonso R, Quirion R, Beaudet A. (1997) Differential binding profile and internalization process of neurotensin via neuronal and glial receptors. J. Neurosci. 17: 1795-1803.
12. Castel MN, Beaudet A, Laduron PM. (1994) Retrograde axonal transport of neurotensin in rat nigrostnatal dopamine neurons, modulation during ageing and possible physiological role. Biochem. Pharmacol 47: 53-62.
13. Martinez-Fong D, Navarro-Quiroga I. (2000) Synthesis of a non-viral vector for targeted gene delivery to cells expressing the high affinity neurotensin receptor. Brain Res. Protocols 6: 13-24.
14. Martinez-Fong D, Navarro-Quiroga I, Ochoa I, Alvarez-Maya I, Meraz MA, Luna J, Arias-Montano JA. (1999) Neurotensin- SPDP-poly-L-lysine conjugate: a nonviral vector for targeted gene delivery to neural cells. Brain Res. Mol. Brain Res. 69: 249-262.
15. Kitabgi P. (1989) Neurotensin modulates dopamine neurotransmission at several levels along brain dopamine pathways. Neurochem. Int 14: 111-119.
16. Gully D, Canton M, Boigegrain R, et al. (1993) Biochemical and pharmacological profile of a potent and selective non-peptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sci. USA 90: 65-69.
17. Waksman G, Bouboutou R, Devin J, et al. (1985) In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Eur. J. Pharmacol. 117: 233-243.
18. Góngora-Alfaro JL, Hemández-López S, Martinez-Fong D, Aceves J. (1996) Circling behavior elicited by cholinergic neurotransmission in the substantia nigra pars compacta: involvement of nicotinic and muscarinic receptors. Neuroscience 71: 729-734.
19. Lepee-Lorgeoux I, Betancur C, Rostene W, Pelaprat D. (1999) Differential onlogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization. Brain Res. Dev. Brain Res. 113: 115-131.
20. Mendez M, Souaze F, Nagano M, Kelly PA, Rostene W, Forgez P. (1997) High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR. J. Mol. Neurosci. 9: 93-102.
21. Paxinos G, Watson C. (1986) The rat brain in stereotaxic coordinates. (2nd edition). New York, Academic Press.
22. Gorman CM, Moffat LF, Howard BH. (1982) Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051.
23. Graham FL, van der Eb AJ. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467.
24. Chao CC, Hu S, Sheng WS, Bu D, Bukrinsky MI, Peterson PK. (1996) Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 16: 276-284.
25. Heuser JE, Anderson RG. (1989) Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol 108: 389-400.
26. 3H]neurotensin binding site in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 333: 400-405.
27. Kitabgi P, Rostene W, Dussaillant M, Schotte A, Laduron PM, Vincent JP. (1987) Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. Eur. J. Pharmacol. 140: 285-293.
28. Mazella J, Zsurger N, Navarro V, et al. (1998) The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem 273: 26273-26276.
29. Mislick KA, Baldeschwieler JD, Kayyem JF, Meade TJ. (1995) Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. Bioconjug. Chem 6: 512-515.
30. Mazella J, Botto J, Guillemare E, Coppola T, Sarret P, Vincent JP. (1996) Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J. Neurosci. 16: 5613-5620.
31. Betancur C, Canton M, Burgos A, Labeeuw B, Gully D, Rostene W, Pelaprat D. (1998) Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain. Eur. J. Pharmacol. 343: 67-77.
32. Sarret P, Beaudet A, Vincent JP, Mazella J. (1998) Regional and cellular distribution of low affinity neurotensin receptor mRNA in adult and developing mouse brain. J. Com. Neurol. 394: 344-356.
33. Clague MJ. (1998) Molecular aspects of the endocytic pathway. Biochem. J. 336: 271-282.
34. Kichler A, Freulon I, Boutin V, Mayer R, Monsigny M, Midoux P. (1999) Glycofection in the presence of anionic fusogenic peptides: a study of the parameters affecting the peptide-mediated enhancement of the transfection efficiency. J. Gene. Med. 1: 134-143.
35. Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ. (1999) Characterization of the 5′-flanking region of the human dopamine transporter gene. Brain Res. Mol Brain. Res 74: 167-174.
36. Beck KD, Valverde J, Alexi T, et al. (1995) Mesencephalic dopamine neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373: 339-341.
37. Klein RL, Lewis MH, Muzyczka N, Meyer EM. (1999) Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer. Brain Res. 847: 314-320.
38. Mandel RJ, Snyder RO, Leff SE. (1999) Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease. Exp. Neurol. 160: 205-214.
39. Serretti A, Lilli R, Lorenzi C, Smeraldi E. (2000) Further evidence supporting the association between the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia. Schizophr. Res. 43: 161-162.